
Panvizyme 212.5mg Tablet
Marketer
Binova Healthcare Pvt Ltd
Salt Composition
Pancreatin (212.5mg)
Overview Panvizyme 212.5mg Tablet
DigestAid 212.5mg tablets are prescribed for pancreatic enzyme insufficiency. This pancreatic enzyme supplement aids digestion, lessening bowel movements and easing stomach upset. Take DigestAid 212.5mg with or immediately after meals and snacks, accompanied by ample water, to optimize enzyme interaction with food. Dosage is individualized based on your health and response. Continue treatment as directed by your physician; long-term use is possible, so establish a consistent intake schedule. DigestAid 212.5mg may be part of a broader treatment plan including dietary modifications. Common side effects include abdominal pain, bloating, and loose stools. Report persistent or bothersome side effects to your doctor, as mitigation strategies may be available. Inform your physician about gout, asthma, allergies, or diabetes (as this medication might influence blood sugar management and your existing diabetes treatment). Avoid concurrent antacid use. Consult your doctor regarding use during pregnancy or breastfeeding. Regular blood tests may be conducted to monitor treatment efficacy.
Primary Ingredients of Panvizyme 212.5mg Tablet
The provided information is insufficient.
Uses of Panvizyme 212.5mg Tablet
Managing insufficient pancreatic enzymes
Major Benefits of Panvizyme 212.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Panvizyme 212.5mg Tablets should be administered with a meal.
Common Side effects of Panvizyme 212.5mg Tablet:
- Stomach pain
- Bloating
- Diarrhea
How to use Panvizyme 212.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Panvizyme 212.5mg Tablet should be administered with a meal.
How Panvizyme 212.5mg Tablet works:
Pancreatic enzyme replacement therapy, pancreatin, aids digestion by readily combining with ingested food.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Panvizyme 212.5mg Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Panvizyme 212.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Panvizyme 212.5mg tablets safely. Available human data indicates minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by Panvizyme 212.5mg tablets.
KidneyCONSULT YOUR DOCTOR
Data regarding Panvizyme 212.5mg Tablet use in individuals with renal impairment is scarce. Physician consultation is advised. Elevated uric acid is a potential concern in patients with pre-existing kidney conditions; therefore, careful monitoring is necessary.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Panvizyme 212.5mg tablets in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Panvizyme 212.5mg Tablet :
Should you forget a Panvizyme 212.5mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Panvizyme 212.5mg Tablet
| Label | Value |
|---|---|
| Pharmaceutical Category | Polypeptides |
| Potential for Dependence | None. |
| Treatment Category | Gastrointestinal tract |
| Mechanism of Action | Agents that aid digestion |
